Genetic examination of SETD7 and SUV39H1/H2 methyltransferases and the risk of diabetes complications in patients with type 1 diabetes.
about
Epigenetic modifications and diabetic retinopathyGenetics of cardiovascular and renal complications in diabetesNuclear receptors and epigenetic signaling: novel regulators of glycogen metabolism in skeletal muscleNew susceptibility loci associated with kidney disease in type 1 diabetes.New insight into the SSC8 genetic determination of fatty acid composition in pigs.DNA hypermethylation and DNA hypomethylation is present at different loci in chronic kidney diseaseGenetic Evidence for a Causal Role of Obesity in Diabetic Kidney Disease.Association of chemokine ligand 5/chemokine receptor 5 gene promoter polymorphisms with diabetic microvascular complications: A meta-analysis.Chromatin modifications associated with diabetes.Glycemic memories and the epigenetic component of diabetic nephropathy.Epigenetic modifications and potential new treatment targets in diabetic retinopathyContribution of epigenetics in diabetic retinopathy.Polycomb repressive complex 2 regulates MiR-200b in retinal endothelial cells: potential relevance in diabetic retinopathyDiabetic retinopathy: Breaking the barrier.The Role of Epigenetics in Type 1 Diabetes.Novel Genetic Actors of Diabetes-Associated Microvascular Complications: Retinopathy, Kidney Disease and NeuropathyEpigenetics in diabetic nephropathy, immunity and metabolism.Epigenetic control of gene regulation during development and disease: A view from the retina.The genetics of retinopathy of prematurity: a model for neovascular retinal disease
P2860
Q21284810-B9851964-8D80-41A2-836F-0B151A8EE7E6Q26752749-84433729-3429-4803-A9E9-BA4D6784DAA8Q27004919-42CDCE05-D894-4657-8E67-67F0B85620E4Q29417066-5CF2FD6B-ACBF-4561-B2CC-9FDDE79C6EB9Q33706516-579B026B-404A-47E4-8D9A-0476313B020DQ33740666-BC25AE70-0728-458F-B971-E388838E7D9BQ36311567-DBAAE98F-990C-4342-9525-307B22CB1C22Q36637953-E5178C14-70B3-43C4-944C-07D65BA452ADQ38013734-D2AB87D3-AE99-4368-AF29-F3128C4C8CC3Q38103744-3347579C-1BE2-425F-BED6-380004EF1151Q38244141-133B8332-B635-45D8-989C-2F3A170D3A4BQ38508141-071A0F84-6146-4C5C-9B86-CD3F248BCAC7Q38885853-DF14BA03-BFDE-4524-B628-94BD4C799716Q39451009-6ADFC90D-B311-457A-B1DB-EAA75477487CQ41437245-E23D06D0-00AB-486A-9921-6ED5E61760F9Q41690327-8D0FDFFA-EB02-4AAD-BF89-5F7E3ED7B8C8Q47412518-FF44A6FE-1BE2-41D4-9976-33B290FD096AQ51762764-368107E7-469C-48A3-A430-714417DC3CD7Q57165717-D2F32521-1DFA-40EF-9109-1A19EBF766DA
P2860
Genetic examination of SETD7 and SUV39H1/H2 methyltransferases and the risk of diabetes complications in patients with type 1 diabetes.
description
2011 nî lūn-bûn
@nan
2011 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Genetic examination of SETD7 a ...... patients with type 1 diabetes.
@ast
Genetic examination of SETD7 a ...... patients with type 1 diabetes.
@en
type
label
Genetic examination of SETD7 a ...... patients with type 1 diabetes.
@ast
Genetic examination of SETD7 a ...... patients with type 1 diabetes.
@en
prefLabel
Genetic examination of SETD7 a ...... patients with type 1 diabetes.
@ast
Genetic examination of SETD7 a ...... patients with type 1 diabetes.
@en
P2093
P2860
P50
P356
P1433
P1476
Genetic examination of SETD7 a ...... patients with type 1 diabetes.
@en
P2093
Hans-Henrik Parving
Maikki Parkkonen
Mark E Cooper
P2860
P304
P356
10.2337/DB11-0073
P407
P50
P577
2011-09-06T00:00:00Z